186 related articles for article (PubMed ID: 7555651)
1. [Cyclosporin in severe steroid-requiring bronchial asthma].
Klein RM; Leschke M; Strauer BE
Dtsch Med Wochenschr; 1995 Oct; 120(40):1349-55. PubMed ID: 7555651
[TBL] [Abstract][Full Text] [Related]
2. Asthma control in a random sample of New Zealand adolescent asthmatics.
van Dalen CJ; Harding E; Parkin J; Blakey K; Cheng S; Pearce NE; Douwes J
J Asthma; 2007 May; 44(4):261-6. PubMed ID: 17530523
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin in steroid dependent asthma.
Mungan D; Misirligil Z; Sin B; Kaya A; Demirel Y; Gürbüz L
Allergol Immunopathol (Madr); 1995; 23(5):202-6. PubMed ID: 8526177
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of maintenance therapy in hospitalized patients with exacerbation of bronchial asthma: a six-year observation].
Sereda VP; Svistov AS
Klin Med (Mosk); 2005; 83(12):36-41. PubMed ID: 16502722
[TBL] [Abstract][Full Text] [Related]
5. Treatment of steroid-dependent bronchial asthma with cyclosporin.
Nizankowska E; Soja J; Pinis G; Bochenek G; Sładek K; Domagała B; Pajak A; Szczeklik A
Eur Respir J; 1995 Jul; 8(7):1091-9. PubMed ID: 7589392
[TBL] [Abstract][Full Text] [Related]
6. Clinical benefits of 7 years of treatment with omalizumab in severe uncontrolled asthmatics.
Pace E; Ferraro M; Bruno A; Chiappara G; Bousquet J; Gjomarkaj M
J Asthma; 2011 May; 48(4):387-92. PubMed ID: 21391878
[TBL] [Abstract][Full Text] [Related]
7. Acute asthma in children: treatment in emergency.
Pavone P; Longo MR; Taibi R; Nunnari G; Romano C; Passaniti E; Falsaperla R
Eur Rev Med Pharmacol Sci; 2011 Jun; 15(6):711-6. PubMed ID: 21796876
[TBL] [Abstract][Full Text] [Related]
8. Severity and control of severe asthma.
Bateman ED
J Allergy Clin Immunol; 2006 Mar; 117(3):519-21. PubMed ID: 16522449
[No Abstract] [Full Text] [Related]
9. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.
Fish JE; Karpel JP; Craig TJ; Bensch GW; Noonan M; Webb DR; Silverman B; Schenkel EJ; Rooklin AR; Ramsdell JW; Nathan R; Leflein JG; Grossman J; Graft DF; Gower RG; Garay SM; Frigas E; Degraff AC; Bronsky EA; Bernstein DI; Berger W; Shneyer L; Nolop KB; Harrison JE
J Allergy Clin Immunol; 2000 Nov; 106(5):852-60. PubMed ID: 11080706
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacologic therapy of bronchial asthma].
Herjavecz I
Orv Hetil; 2003 Aug; 144(33):1639-40. PubMed ID: 14564926
[No Abstract] [Full Text] [Related]
11. [A complex evaluation of the efficacy of aldecin in treating bronchial asthma patients].
Kakhnovskiĭ IM; Marinin VF; Arkhipova SV; Sorokina LA
Ter Arkh; 1998; 70(3):22-5. PubMed ID: 9575582
[TBL] [Abstract][Full Text] [Related]
12. [Inhaled corticotherapy in asthma: when should it be started and how to stop?].
Aubier M
Rev Pneumol Clin; 1996; 52(2):145-9. PubMed ID: 8761645
[TBL] [Abstract][Full Text] [Related]
13. Omalizumab treatment and exercise capacity in severe asthmatics - results from a pilot study.
Schäper C; Gläser S; Felix SB; Gogolka A; Koch B; Krüll M; Ewert R; Noga O
Respir Med; 2011 Jan; 105(1):3-7. PubMed ID: 20739169
[TBL] [Abstract][Full Text] [Related]
14. Suboptimal use of inhaled corticosteroids in children with persistent asthma: inadequate prescription, poor drug adherence, or both?
Pando S; Lemière C; Beauchesne MF; Perreault S; Forget A; Blais L
Pharmacotherapy; 2010 Nov; 30(11):1109-16. PubMed ID: 20973684
[TBL] [Abstract][Full Text] [Related]
15. Determinants of asthma control in tertiary level in Turkey: a cross-sectional multicenter survey.
Turktas H; Mungan D; Uysal MA; Oguzulgen K;
J Asthma; 2010 Jun; 47(5):557-62. PubMed ID: 20560829
[TBL] [Abstract][Full Text] [Related]
16. [Bronchial reactivity as factor of effectiveness of new antiasthmatic drugs].
Pol'ner SA; Chervinskaia TA
Ter Arkh; 2000; 72(3):20-3. PubMed ID: 10776647
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
Jiang YW; Sun YC; Zhou QT; Gai XY; Cao WL; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):447-51. PubMed ID: 17673020
[TBL] [Abstract][Full Text] [Related]
18. [Problems in the treatment of aggravated bronchial asthma].
Khanina SB; Shudinovskikh AIa
Klin Med (Mosk); 1974 Dec; 52(12):86-90. PubMed ID: 4444252
[No Abstract] [Full Text] [Related]
19. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
[TBL] [Abstract][Full Text] [Related]
20. The use of cyclosporin in corticosteroid dependent asthma.
Coren ME; Rosenthal M; Bush A
Arch Dis Child; 1997 Dec; 77(6):522-3. PubMed ID: 9496189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
